| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |